The immunological and genetic pathogeneses of inflammatory bowel disease (IBD) have
been well studied, but not well elucidated in recent years. Accordingly, the pharmacological …

Despite all of the advances in our understanding of the pathophysiology of inflammatory
bowel disease (IBD), we still do not know its cause. Some of the most recently available data …

Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disorder with an
unknown etiology. IBD is composed of two different disease entities: Crohn's disease (CD) …

Inflammatory bowel disease (IBD) is a term used to represent a group of chronic, relapsing
inflammatory disorders of the gastrointestinal tract. Crohn's disease (CD) and ulcerative …

Three domains are accepted components of the etiology of inflammatory bowel disease
(IBD): genetic predisposition, environmental stimuli, and abnormal immune response. The …

In recent years, the incidence of inflammatory bowel disease (IBD) has been on the rise,
extending to countries where it was infrequent in the past. As a result, the gap between high …

Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the
gastrointestinal tract, which clinically present as one of two disorders, Crohn's disease or …

The inflammatory bowel diseases have undergone an explosion of discovery in the last 10
years. The overwhelming focus of this has been in genetics and immune mechanisms of …

Recent studies have provided important insights into the pathogenesis of inflammatory
bowel disease (IBD). The development of new therapeutic agents has been triggered by …

In this review, we speculate about future therapeutic approaches for inflammatory bowel
diseases (IBDs), focusing on the need for better preclinical and clinical models and …